↓ Skip to main content

Cochrane Database of Systematic Reviews

Cannabinoids for Tourette's Syndrome

Overview of attention for article published in Cochrane database of systematic reviews, October 2009
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
127 Mendeley
Title
Cannabinoids for Tourette's Syndrome
Published in
Cochrane database of systematic reviews, October 2009
DOI 10.1002/14651858.cd006565.pub2
Pubmed ID
Authors

Adrienne Curtis, Carl E Clarke, Hugh E Rickards

Abstract

Gilles de la Tourette Syndrome (GTS) is a developmental neuropsychiatric disorder characterised by the presence of chronic motor and phonic tics. Drugs currently used in the treatment of GTS either lack efficacy or are associated with intolerable side effects. There is some anecdotal and experimental evidence that cannabinoids may be effective in treating tics and compulsive behaviour in patients with GTS. There are currently no systematic Cochrane reviews of treatments used in GTS. There is one other Cochrane review being undertaken at present, on the use of fluoxetine for tics in GTS.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 126 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 17%
Student > Ph. D. Student 13 10%
Student > Master 13 10%
Student > Bachelor 9 7%
Student > Postgraduate 9 7%
Other 29 23%
Unknown 32 25%
Readers by discipline Count As %
Medicine and Dentistry 43 34%
Psychology 11 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Biochemistry, Genetics and Molecular Biology 7 6%
Agricultural and Biological Sciences 5 4%
Other 18 14%
Unknown 35 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 64. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2022.
All research outputs
#524,164
of 21,732,065 outputs
Outputs from Cochrane database of systematic reviews
#1,056
of 12,105 outputs
Outputs of similar age
#2,136
of 131,777 outputs
Outputs of similar age from Cochrane database of systematic reviews
#5
of 73 outputs
Altmetric has tracked 21,732,065 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,105 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 131,777 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.